Jan Kotarski

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy

Dongjun Peng, Ilona Kryczek, Nisha Nagarsheth et al. · Nature · 2015 · 1.2K citations · Full text

Epigenetic Silencing, Tumor Immunology, Cancer Immunosurveillance +7

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist

Hugh S. Taylor, Linda C. Giudice, Bruce A. Lessey et al. · New England Journal of Medicine · 2017 · 466 citations · Full text

Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer

Weimin Wang, Ilona Kryczek, Lubomír Dostál et al. · Cell · 2016 · 420 citations · Full text

Cancer Immunosurveillance, Medicine, Tumor Immunity +5

Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2

Tracy X. Cui, Ilona Kryczek, Lili Zhao et al. · Immunity · 2013 · 414 citations · Full text

Tumor Biology, Corepressor Ctbp2, Medicine +14

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

Ende Zhao, Tomasz Maj, Ilona Kryczek et al. · Nature Immunology · 2015 · 397 citations · Full text

Tumor Biology, Cancer Immunosurveillance, T Cell Dysfunction +10